Your browser doesn't support javascript.
loading
Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.
Winston, Drew J; Mullane, Kathleen M; Cornely, Oliver A; Boeckh, Michael J; Brown, Janice Wes; Pergam, Steven A; Trociukas, Igoris; Zák, Pavel; Craig, Michael D; Papanicolaou, Genovefa A; Velez, Juan D; Panse, Jens; Hurtado, Kimberly; Fernsler, Doreen A; Stek, Jon E; Pang, Lei; Su, Shu-Chih; Zhao, Yanli; Chan, Ivan S F; Kaplan, Susan S; Parrino, Janie; Lee, Ingi; Popmihajlov, Zoran; Annunziato, Paula W; Arvin, Ann.
Afiliación
  • Winston DJ; Department of Medicine, University of California Los Angeles Medical Center, Los Angeles, CA, USA. Electronic address: dwinston@mednet.ucla.edu.
  • Mullane KM; University of Chicago Department of Medicine, Chicago, IL, USA.
  • Cornely OA; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, Department I of Internal Medicine, Clinical Trials Centre Cologne (ZKS Köln), German Centre for Infection Research (DZIF), University of Cologne, Cologne, Germany.
  • Boeckh MJ; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Brown JW; Stanford University School of Medicine, Stanford, CA, USA.
  • Pergam SA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Trociukas I; Vilnius University Hospital, Vilnius, Lithuania.
  • Zák P; Department of Medicine, Fakultní nemocnice Hradec Králové, Hradec Králové, Czech Republic.
  • Craig MD; West Virginia University Hospitals, Morgantown, WV, USA.
  • Papanicolaou GA; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Velez JD; Fundación Valle del Lilí, Cali, Colombia.
  • Panse J; Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, University Hospital RWTH Aachen, Aachen, Germany.
  • Hurtado K; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Fernsler DA; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Stek JE; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Pang L; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Su SC; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Zhao Y; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Chan ISF; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Kaplan SS; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Parrino J; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Lee I; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Popmihajlov Z; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Annunziato PW; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Arvin A; Stanford University School of Medicine, Stanford, CA, USA.
Lancet ; 391(10135): 2116-2127, 2018 05 26.
Article en En | MEDLINE | ID: mdl-29856344
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Vacuna contra el Herpes Zóster / Herpes Zóster Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Vacuna contra el Herpes Zóster / Herpes Zóster Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido